Tris-CAR-T Cell Therapy for Recurrent Glioblastoma

NCT05577091 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Glioblastoma

Interventions

GENETIC: Inverse correlated dual-target, truncated IL7Ra modified CAR -expressing autologous T-lymphocytes.

Sponsor

Beijing Tiantan Hospital

Collaborators

[object Object]
[object Object]